Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    

SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

Chelsea Therapeutics International Ltd. : Chelsea Therapeutics International and Fortress Investment Group Review: (NASDAQ: CHTP), (NYSE: FIG)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2013 | 06:05pm CEST

New York (March 13th, 2013) - Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shows bullish trend as the stock made a sharp movement in its latest trading session. It opened the session at $1.95 and remained in $1.92 and $2.00 price range during the session. The stock is 2.59 percent higher at $1.98. Chelsea Therapeutics’ first support level is at $1.95. Upon breaching this level, the stock may go as low as $1.89. On the upside, its first resistance level is at $2.03.

Chelsea Therapeutics is a pharmaceutical company and is based out of North Carolina.

Find out if this is the moment investors been waiting for before trading CHTP here:

http://www.wallstreetscoop.net/market-scan/?symbol=CHTP


Fortress Investment Group LLC (NYSE: FIG) stock is at $6.84, up 2.09 percent from its previous close of $6.70. The stock opened the session at $6.98 which is also its highest price point for the session. Fortress Investment stock’s lowest price point for the session stood at $6.765. The stock is currently above its 6-days EMA of $6.76 and 20 days EMA of $6.36, thus showing bullish trend. Its MACD chart also shows bullish trend and the stock is likely to make up movement to $6.95 in coming trading sessions.

Fortress Investment is based out of New York and is operational in Europe and Asia.

Find out more on FIG here:

http://www.wallstreetscoop.net/market-scan/?symbol=FIG

About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:

Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CHELSEA THERAPEUTICS INTER
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
2014 CHELSEA THERAPEUTICS : Shareholder Alert: Former SEC Attorney Willie Briscoe and..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investi..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 CHELSEA THERAPEUTICS : Newman Ferrara LLP : Announces Investigation of Chelsea T..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Brower Piven Announces the Investigati..
2014 CHELSEA THERAPEUTICS : Law Firm Kirby McInerney LLP Investigating Potential Clai..
2014 CHELSEA THERAPEUTICS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Inves..
2014 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
2014 Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day
More news
Income Statement Evolution
Managers
NameTitle
Staffan Schüberg President & Director
Julie Hakim Secretary, Treasurer & Director
Sector and Competitors
1st jan.Capitalization (M$)
CHELSEA THERAPEUTICS INTERNATIONAL LTD.0
AMGEN14.42%122 067
CELGENE CORPORATION10.28%99 867
GILEAD SCIENCES0.70%94 170
REGENERON PHARMACEUTICALS26.41%50 145
VERTEX PHARMACEUTICALS101.07%37 346